|
|
|
| home > pmps > winter 2001 > digital printing for pharmaceutical packaging - a customer's perspective |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
As digital printing becomes a more viable option for packaging, printing vendors are looking to the pharmaceutical industry as a lucrative market. There are several reasons why digital printing is suitable for pharmaceutical packaging:
The option of quick turnaround for printed materials is
especially attractive in an industry which is under increasing
pressure to bring products to launch
Frequent changes to packaging make any options which
reduce the inventory of printed materials very advantageous
Rapid safety changes are often necessary for
pharmaceutical products
While the cost of printed materials is not a major portion
of the cost of the product for large orders of pharmaceutical
products, this is not always true for short run, small volume
products.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Innovative Micro-Infusion Pump for Gerresheimer Subsidiary Sensile Medical Developed and Successfully Launched for EVER Pharma
Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical
for EVER Pharma under the brand name D-mine®, this wearable
microinfusion pump recently received European CE certification and has
already been launched in several European countries. The compact,
patient-friendly infusion pump is used for the continuous subcutaneous
administration of drugs to treat Parkinson’s disease. The first micro
pump from Gerresheimer subsidiary Sensile Medical to be available on the
market, it gives Parkinson’s patients greater independence in their
day-today lives.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: 2nd Quarter 2014
Synergy Research Group
The Ministry of Health of Russian Federation approved 194 new clinical
trials of all types including local and bioequivalence studies during
the 2nd Quarter of 2014 (3% less than at the same period of the last
year).
The main contribution to the total number of studies was
made by multinational multi-center clinical trials (MMCT) and the number
of these studies stayed the same as in Q2 2013 – 81 studies. The number
of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to
59 in Q2 2014, a 22% decrease from last year’s figure. The number of
local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical
trials in Q2 2014.
More info >> |
|
 |
Industry Events |
 |
The Universe of Pre-filled Syringes and Injection Devices
22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel
PDA’s Universe of Pre-filled Syringes and Injection
Devices has become the must-attend meeting for everyone
working in the field, and is now the world’s largest conference on this subject
More info >> |
|
|
